ICTS Success Stories
Nancy Tye-Murray, PhD (Otolaryngology) used CTRFP funding and an ICTS-supported LEAP Challenge grant in 2015 to identify markets and plug into the StL entrepreneurial community to launch the clEAR start-up. clEAR is an Internet business that provides customized auditory training exercises for people with hearing loss through engaging computer games. View timeline (pdf)
Peter Nagele, MD, MS, was enrolled in the Postdoctoral Mentored Training Program in Clinical Investigation (MTPCI) as an instructor in 2007, promoted to Assistant Professor in July 2008, and subsequently developed into an independent investigator in 2015 (R01). In 2010, he was funded under the K23 program through the National Institute of General Medical Sciences. […]
Ana Maria Arbelaez, MD, MSCI (Pediatrics), used the Mentored Training Program in Clinical Investigation (MTPCI) and the KL2 Scholar programs on her career pathway to independent investigator status. She now serves as Associate Director of the TL1 Predoctoral Interdisciplinary Training Program (ICTS TL1 grant) and has recently been appointed as interim Chief of the Pediatric […]
The Dissemination & Implementation Research Core (DIRC), directed by Enola Proctor, PhD, MSW, has contributed locally and nationally in dissemination and implementation science and in training. The core was established to help investigators “design for dissemination” by moving evidence-based practices to real-world use. Learn how the core and its director speed the adoption and delivery […]
Congratulations to national leader Methodius Tuuli, MD, who was recently recognized with a Top 10 Clinical Research Achievement Award from the Clinical Research Forum. Awards exemplify exceptional publications that contribute to the knowledge of health and disease resulting from national investment in clinical and translational research.
2012 SPIRiT Pilot awardee, Daniel Ory, MD, moved a newly approved FDA-therapy to Phase 2b/3 clinical trials for Niemann-Pick type C1 (NPC1) disease. The research was featured in an NCATS Information release highlighting the Therapeutics for Rare and Neglected Diseases (TRND) Program and a recent paper describing the process for fostering collaborative research for rare genetic […]
Leveraging 2011 Pilot funding and a 2016 JIT award to use services from the Regulatory Support Center (RSC), Fumihiko Urano, MD, PhD, secured IND approval for the use of dantrolene sodium in treatment of Wolfram Syndrome treatment. The first patients were enrolled in the Dantrolene Clinical Trial — NCT02829268 in Feb 2017. Learn more about […]